true

BD Nexiva Diffusics™ Catheter System

Gain clarity where it counts

Background Image
BD Nexiva™ Diffusics™ Closed IV Catheter System

Ready to learn more? Let’s have a conversation.

Loading
Designed With CT Scans in Mind

The BD Nexiva™ Diffusics™ Closed IV Catheter System is built upon the BD Nexiva™ Diffusics™ Closed IV Catheter System with the added benefit of a diffusion catheter tip designed to address common IV challenges in CT, such as sufficient gauge size and catheter stability in the vein, during power injection procedures.

true

Common CT Infusion Challenges

High flow rates have traditionally required large gauge catheters

Unfortunately, many patients’ vasculature cannot accommodate 18- or even 20-gauge catheters, and using smaller gauge sizes can result in slower flow rates and reduced image quality.

High flow rates may cause catheters to whip around in the vein.

While achieving appropriate flow rates is crucial to image quality, the high flow rates required for power injection during CT may also cause catheters to move or whip around in the vein which may lead to extravasation and could be costly.1,2

Enable higher flow rates with smaller gauges

The Infusion Therapy Standards of Practice recommend placing the smallest-gauge catheter that will accommodate the prescribed therapy and patient need.3

The diffusion tip on Nexiva Diffusics™ Catheter System enables desired contrast media flow rates to be achieved using a smaller gauge catheter† without compromising image quality. This enables clinicians to perform CT scans that require high flow rates when a patient's vasculature cannot accommodate a large catheter (i.e., 18 or 20 gauge).‡,4 

22–24 gauge

Bench test results may not necessarily be indicative of clinical performance.

Reduce the force of contrast delivery

While flow rates of contrast media are important, the delivery force should also be considered. Nexiva Diffusics™ Catheter System’s diffusion tip reduces the force of contrast delivery by up to 48%,§ helping decrease the impact of contrast media on the vessel wall.

§Compared to a non-diffusion-tip catheter. Bench test results may not necessarily be indicative of clinical performance.

Decrease potential catheter motion in vein

High flow rates required for power injection during CT may cause some catheters to move or whip around in the vein. Catheter motion may lead to extravasation, a complication caused by the catheter backing out of the vein.1

Extravasation may be painful for the patient, potentially resulting in tissue damage.3 The average potential liability for a moderate extravasation is $22k and up to $145k for a severe extravasation.2

Nexiva Diffusics™ Catheter System has been shown to reduce the forces that may cause catheter motion in the vein by up to 67%. This reduction in force stabilizes the catheter in the vein, and prevents the whipping, movement and backing out of the vein that may lead to extravasation.1

The videos below show catheter motion and extravasation of a non-diffusion tip catheter compared to the stability that Nexiva Diffusics™ Catheter System provides during power injection.


Power injection through a non-fenestrated catheter: Extravasation

Video Player is loading.
Current Time 0:00
/
Duration 0:26
Loaded: 0.00%
0:00
Stream Type LIVE
Remaining Time -0:26
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Note that, due to the force of the injection, the catheter tip will slowly move, backing out of the vein until the tip escapes the vein completely and contrast media enters the surrounding tissue.


    Power injection through a non-fenestrated catheter: Catheter Motion

    Video Player is loading.
    Current Time 0:00
    /
    Duration 0:39
    Loaded: 0.00%
    0:00
    Stream Type LIVE
    Remaining Time -0:39
     
    1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • en (Main), selected

      Note the catheter stays in the vein, but the forces from the power injection create enough turbulence to cause the catheter tip to whip around within the vein. This creates significant motion, potentially irritating or damaging the vessel wall.


      Power injection through Nexiva Diffusics™ Catheter System with fenestrated tip: Stability

      Video Player is loading.
      Current Time 0:00
      /
      Duration 0:24
      Loaded: 0.00%
      0:00
      Stream Type LIVE
      Remaining Time -0:24
       
      1x
        • Chapters
        • descriptions off, selected
        • captions off, selected
        • en (Main), selected

         Note the contrast media flows throughout the vasculature, while the catheter remains still.


        Videos are from an animal study. Animal study results may not be indicative of clinical performance.

        Explore Our Portfolio

        Nexiva Diffusics™ Catheter System Portfolio

        Nexiva Diffusics™ Catheter System is offered in two single port configurations: with and without BD MaxZero™ Needle-free Connectors.

        Partner with BD

        Together we can elevate care. Our specialists are here to help.  Let's get started.

        BD Nexiva Diffusics™ Catheter System
        Ready to learn more? Let’s have a conversation.

        References

        1. Boschi R, Rostagno R. Extravasation of antineoplastic agents: prevention and treatments. Pediatric Reports. 2021;4(e28);98-100.
        2. Paice T. Economic impact of an extravasation. an analysis. Imaging Economics. 2007;20(3):14.
        3. Infusion Nurses Society. Infusion therapy standards of practice. J Infus Nurs. 2024.
        4. Johnson PT, Christensen GM, Fishman EK. IV contrast administration with dual source 128-MDCT: a randomized controlled study comparing 18-gauge nonfenestrated and 20-gauge fenestrated catheters for catheter placement success, infusion rate, image quality and complications. Am J Roentgenol. 2014;202(6):1166-70.

        BD-22672 (05/24)

        <p> </p>
<p>Nexiva Diffusics™ Catheter System for cardiac CTs</p>

         

        Nexiva Diffusics™ Catheter System for cardiac CTs

        The all-in-one closed IV catheter system leverages a fenestrated tip to accommodate power injection at high flow rates (e.g., 6.5 mL/sec for 22 G) and provides higher vascular attenuation for coronary CTA (CCTA) when compared with non-fenestrated catheters at the same flow rates.



        Practice guidelines include using a fenestrated peripheral IV catheter (PIVC), ensuring the IV used is rated to administer flow rates required for coronary CTA (e.g., 5–7 mL/s).1

        CCTA benefits

        • ensures high risk patients are appropriately triaged to cardiac catheterization1

        • offers rapid evaluation of the degree of coronary stenosis and atherosclerosis1

        • allows significant reduction in time-to-discharge1

        CCTA conditions

        • Appropriate utilization and patient selection1

        • Requires high contrast media injection flow rates2

        Extracting potential clinical and economic value for CCTA includes improving patient outcomes, lowering healthcare costs and preventing unnecessary diagnostic procedures.1

        On-Demand Webinar

        Watch a free webinar featuring Dr. Wesley T. O’Neal, MD, FACC, Medical Director, Cardiovascular CT Cone Health Heart & Vascular Center of Greensboro NC

        The Nexiva Diffusics™ Advantage

        Elevate infusion experiences for your patients

        Fenestrated catheter in CCTA1,2

        <p>Diagnostic, high-quality images</p> <p>Diagnostic, high-quality images</p>

        Diagnostic, high-quality images

        Expedite triage Expedite triage
        Expedite triage
        Reduce risk of complications<sup>3</sup> Reduce risk of complications<sup>3</sup>
        Reduce risk of complications3

        Achieving high diagnostic accuracy with the lowest possible radiation dose requires careful preparation of CTA patients.1 Adequate peripheral IV access is necessary to ensure diagnostic, high-quality images.2

        Image quality is affected by the attenuation achieved in MDCT coronary angiography, particularly in the small coronary arteries. Overall diagnostic accuracy improves significantly when higher intracoronary attenuation is achieved.4 Nexiva Diffusics™ Catheter System has been shown to provide higher vascular attenuation for CCTA when compared with non-fenestrated catheters at the same flow rates.*,5,6

        Morbid obesity in CCTA
        Morbid obesity is a scenario where CCTA may be difficult or non-diagnostic. Strategies to improve image quality include ensuring high-flow IV contrast injections of 6–7 mL/sec.1 Nexiva Diffusics™ Catheter System can accommodate power injection at 6.5 mL/sec for 22 G and up to 15 mL/sec for 18 G.

        *The catheter system has been tested at the flow rates noted for contrast media viscosity 27.5 cP(mPa-s). However, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings, these flow rates may not be achievable.

        Explore Our Portfolio

        Nexiva Diffusics™ Catheter System Portfolio

        Nexiva Diffusics™ Catheter System is offered in two single port configurations: with and without BD MaxZero™ Needle-free Connectors.

        Partner with BD

        Together we can elevate care. Our specialists are here to help.  Let's get started.

        BD Nexiva Diffusics™ Catheter System
        Ready to learn more? Let’s have a conversation.

        References

        1. Maroules C, Rybicki F, Ghoshhajra B, et al. 2022 use of coronary computed tomographic angiography for patients presenting with acute chest pain to the emergency department. Journal of Cardiovascular Computed Tomography. 2023;17:146-163. https://doi.org/10.1016/j.jcct.2022.09.003.
        2. Fischer AM, Riffel P, Henzier T, et al. More holes, more contrast? Comparing an 18-gauge non-fenestrated catheter with a 22-gauge fenestrated catheter for cardiac CT. PLoS ONE 15(6):e0234311. https://doi.org/10.1371/journal.pone.0234311
        3. Boschi R, Rostagno R. Extravasation of antineoplastic agents: prevention and treatments. Pediatric Reports. 2021;4(e28);98-100.
        4. Cademartiri F, Mollet N, Lemos P, et al. Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography. AJR. 2006;187:W430-W433. doi:10.2214/AJR.05.1406
        5. Harraz M, Abouissa A, Kamr W. Closed versus conventional IV catheter in performing coronary CT Angiography. Egyptian Journal of Radiology and Nuclear Medicine. (2020) 51:89. https://doi.org/10.118/s43055-020-00211-4.
        6. Kim JeongJae, Kim Eun Jeong, Hur Jee Hye, et al. The Usefulness of Fenestrated Intravenous Catheters Compared with Nonfenestrated Catheter for Cardiac Multidetector Computed Tomography. J Comput Assist Tomogr. Volume 43, Number 3, May/June 2019.
        7. González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
        8. Infusion Nurses Society. Infusion therapy standards of practice. J Infus Nurs. 2024.

        Clinical evidence

        Nexiva Diffusics™ Catheter System is built on the Nexiva™ platform. Nexiva™ has been shown to deliver higher clinician satisfaction, improved clinician safety and a reduction in overall complication rates versus non-integrated, open systems.1–3

        The platform is backed by evidence in peer-reviewed journals from as early as 20094 to as recently as 2024.5

        Nexiva™ Diffusics Closed IV Catheter System is also backed by peer-reviewed journals and infusion guidelines. Infusion Therapy Standards of Practice state to consider a fenestrated catheter for a contrast-based radiographic study and in coronary CTA.6 Nexiva Diffusics™ Catheter System is the only peripheral IV catheter with a diffusion catheter tip specifically designed for power injection.

        Closed IV Catheter System

        Comparative 
catheter

        Data gathered

        Year published

        Study type

        Journal

        Authors

        Nexiva Diffusics™Smiths Jelco
        ProtectIV®
Plus
        Aortic enhancement levels, catheter placement success, complications, contrast volume, extravasation, image quality, infusion rate, maximum pressure2014RCT7American Journal
        of Roentgenology
        Johnson PT,
        Christensen GM, Fishman EK.
        Nexiva™VariousCatheter failure, dislodgement, occlusion, phlebitis2024Systematic review/
        meta analysis5
        Journal of Vascular
        Access
        Gidaro A, Quici M, Giustivi D, et al.
        Nexiva™BD Insyte
        Autoguard™
        Dwell time, complications, dislodgement, occlusion, infiltration, phlebitis2023RCT8European Journal
        of Oncology Nursing
        Gerceker GO, 

        Yildirim BG, 

        Onal A, et al.
        Nexiva™B. Braun 
Introcan 
Safety®

        BD Insyte 

        Autoguard™
        Catheter-associated bloodstream infection,
        clinician satisfaction, cost savings/utilization reduction, dwell time, dislodgement/leaking, infiltration/extravasation, local infection, insertion success, occlusion, phlebitis
        2022RCT1Journal of Hospital MedicineRickard CM, 

        Larsen E, 

        Walker RM, et al.
        Nexiva™Smiths Jelco ProtectIV® PlusClinician satisfaction, dwell time, infection, infiltration, pain, phlebitis2019Prospective, quasi-experimental9Journal of Infusion
        Nursing
        Penoyer D, Fowler S, Bennett M
        Nexiva™NoneBlood exposure, dislodgement, kinking, leaking,
        phlebitis, restarts
        2017Observational10Journal of Vascular
        Access
        deRosenroll A
        Nexiva™MedikitBending and kinking, blood exposure, cost savings/utilization reduction, dislodgement, dwell time, extravasation, insertion success, obstruction, phlebitis2014Quasi-randomized study11Journal of Vascular
        Access
        Tamura N, Abe S, Hagimoto K, et al.
        Nexiva™
        B. Braun
        Vasocan® Safety
        Catheter-related infection, cost savings/utilization reduction, dwell time, infiltration/extravasation, insertion success, occlusion, pain, painful hematoma, phlebitis2014RCT2
        Journal of Hospital Infection
        González López J,
        Arribi Vilela A, Fernández Del,
        Palacio E, et al.
        Nexiva™
        B. Braun Introcan Safety® 
        (non-winged)
        with StatLock
        Clinician satisfaction, cost savings/utilization reduction, dislodgement, dwell time, infiltration, insertion success,
        leaking, phlebitis
        2010RCT3Journal of Infusion
        Nursing
        Bausone-Gazda D, Lefaiver CA,
        Walters SA, et al.
        Nexiva™
        NoneClinician satisfaction, clotting, dislodgement, infiltration, leaking, restarts, securement2009Pre-and post-use survey4Journal of the
        Association of
        Vascular Access
        McNeil E, Hines N, Phariss R

         

        Partner with BD

        Together we can elevate care. Our specialists are here to help.  Let's get started.

        BD Nexiva Diffusics™ Catheter System
        Ready to learn more? Let’s have a conversation.

        References

        1. Rickard CM, Larsen E, Walker Rachel M, et al. Integrated versus nonintegrated peripheral intravenous catheter in hospitalized adults (OPTIMUM): A randomized controlled trial. J Hosp Med. 2022;1-12.
        2. González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
        3. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371-384.
        4. McNeil E, Hines N, Phariss R. A clinical trial of a new all-in-one peripheral-short catheter. JAVA. 2009;14(1):46-51.
        5. Gidaro A, Quici M, Giustivi D, et al. Integrated short peripheral intravenous cannulas and risk of catheter failure: a systematic meta-analysis. J Vasc Access. 2024.
        6. Infusion Nurses Society. Infusion therapy standards of practice. J Infus Nurs. 2024.
        7. Johnson PT, Christensen GM, Fishman EK. IV contrast administration with dual source 128-MDCT: a randomized controlled study comparing 18-gauge nonfenestrated and 20-gauge fenestrated catheters for catheter placement success, infusion rate, image quality and complications. Am J Roentgenol. 2014;202(6):1166-70.
        8. Gerceker GO, Yildirim BG, Onal A, et al. The effect of the closed intravenous catheter system on first insertion success, indwelling time, and complications in pediatric hematology and oncology patients: a randomized controlled study. Eur J Oncol Nurs. 2023 Dec:67:102430. doi: 10.1016/j.ejon.2023.102430. Epub 2023 Oct 7.
        9. Penoyer D, Fowler S, Bennett M. Evaluation of the Use of Open Versus Closed Short Peripheral Catheters on Catheter Dwell Time. J Infus Nurs. 2019;42(6):276-282.
        10. deRosenroll A. Peripheral intravenous catheters: Improving outcomes through change in products, clinical practice and education. Vasc Access. 2017;11(1):7-12.
        11. Tamura N, Abe S, Hagimoto K, et al. Unfavorable peripheral intravenous catheter replacements can be reduced using an integrated closed intravenous catheter system. J Vasc Access. 2014;15(4):257-263.

        BD Nexiva Diffusics™ Catheter System

        • 1
        • 2
        • 3
        • 4
        • 5
        • 6
        • 7
        • 8
        • 9
        • 10

        Vent plug

        During insertion, the vent plug allows air to escape from the system enabling blood return to be seen in the catheter and extension tubing. The vent plug seals when blood reaches it, containing the blood within the system.

        Single port

        The port is designed for the administration of a single solution after attaching a needle-free connector.

        Pinch clamp

        The pinch clamp is used to control the flow of blood within the extension tubing and prevent blood leakage when replacing the vent plug or changing the needle-free connector. Each type of needle-free connector has a specified clamping sequence.

        Pre-attached extension tube

        The pre-attached extension tube, combined with the vent plug, creates a closed/integrated system that contains the blood as the catheter is inserted and serves as a secondary flashback chamber to support first attempt insertion success.

        Ergonomic grip

        The ergonomic grip is utilized during insertion and advancement of the catheter. After catheter advancement, pulling back on the white component releases the grey push tab component.

        Passive safety mechanism

        The passive safety mechanism fully encapsulates the needle tip as the needle is withdrawn and the gray push-tab component releases from the built-in stabilization platform. This helps reduce the risk of needlestick injury.

        Stabilization platform

        The built-in stabilization platform facilitates securement of the catheter to the patient and eliminates the need to purchase and add an external stabilization device, as is necessary with non-integrated PIVCs.

        BD Vialon™ Catheter Material

        The catheter resides within the vein and is made of a proprietary polyurethane named Vialon™ Catheter Material, which is differentiated from competitive polyurethane catheters and is utilized only in BD PIVCs.

        BD Instaflash™ Needle Technology

        Instaflash™ Needle Technology is the hole in the needle that allows blood to flow between the needle and the catheter so initial blood return is seen in the catheter. Blood continues to flow up the integrated extension set as confirmation of placement.

        Diffusion tip technology

        The diffusion tip technology is designed to address common IV challenges in CT, such as sufficient gauge size and catheter stability in the vein during power injection. 

         

        Catalog no.

        Color

        Gauge

        Catheter length (in)

        Gravity flow rate
(mL/min)

        Maximum power
        injector pressure
        limit setting (psi)

        Max power
        injector
        flow rate
        for contrast
        media viscosity
        27.5 cP (mPa-s)*
        (mL/sec)

        383590Yellow240.75213253.00 mL/sec
        383591Blue221.00453256.50 mL/sec
        383592Pink201.006832510.00 mL/sec
        383593Pink201.256432510.00 mL/sec
        383594Green181.259032515.00 mL/sec

         

        *The catheter system has been tested at flow rates; however, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings these flow rates may not be achievable.


        BD Nexiva Diffusics™ Catheter System with BD MaxZero™ Needle-free Connectors

        • 1
        • 2
        • 3
        • 4
        • 5
        • 6
        • 7
        • 8
        • 9
        • 10
        • 11

        BD MaxZero™ Needle-Free Connector

        Needle-free connectors close the system while enabling access for delivery of infusion therapy.

        Needle-free connectors must be purchased separately from open/non-integrated PIVCs.

        Vent plug

        During insertion, the vent plug allows air to escape from the system enabling blood return to be seen in the catheter and extension tubing. The vent plug seals when blood reaches it, containing the blood within the system.

        Single port

        The port is designed for the administration of a single solution after attaching a needle-free connector.

        Pinch clamp

        The pinch clamp is used to control the flow of blood within the extension tubing and prevent blood leakage when replacing the vent plug or changing the needle-free connector. Each type of needle-free connector has a specified clamping sequence.

        Pre-attached extension tube

        The pre-attached extension tube, combined with the vent plug, creates a closed/integrated system that contains the blood as the catheter is inserted and serves as a secondary flashback chamber to support first attempt insertion success.

        Ergonomic grip

        The ergonomic grip is utilized during insertion and advancement of the catheter. After catheter advancement, pulling back on the white component releases the grey push tab component.

        Passive safety mechanism

        The passive safety mechanism fully encapsulates the needle tip as the needle is withdrawn and the gray push-tab component releases from the built-in stabilization platform. This helps reduce the risk of needlestick injury.

        Stabilization platform

        The built-in stabilization platform facilitates securement of the catheter to the patient and eliminates the need to purchase and add an external stabilization device, as is necessary with non-integrated PIVCs.

        BD Vialon™ Catheter Material

        The catheter resides within the vein and is made of a proprietary polyurethane named Vialon™ Catheter Material, which is differentiated from competitive polyurethane catheters and is utilized only in BD PIVCs.

        BD Instaflash™ Needle Technology

        Instaflash™ Needle Technology is the hole in the needle that allows blood to flow between the needle and the catheter so initial blood return is seen in the catheter. Blood continues to flow up the integrated extension set as confirmation of placement.

        Diffusion tip technology

        The diffusion tip technology is designed to address common IV challenges in CT, such as sufficient gauge size and catheter stability in the vein during power injection. The unique diffusion tip adds three teardrop-shaped holes to diffuse flow.

        Catalog no.

        Color

        Gauge

        Catheter
        length (in)

        Catheter
        ID in (mm)

        Catheter
        OD in (mm)

        Extension
        tube ID
        (mm)

        Gravity
        flow rate
        (mL/min)

        Max power
        injector
        flow rate
        for contrast
        media viscosity
        27.5 cP (mPa-s)*
        (mL/sec)

        Packaging

        383595Yellow24.750.0210
        (0.53)
        0.0280
        (0.71)
        1.22213.020/box 80/
        case
        383596Blue221.000.0265
        (0.67)
        0.0355
        (0.90)
        1.22456.520/box 80/
        case
        383598Blue221.750.0265
        (0.67)
        0.0355
        (0.90)
        1.65335.020/box 80/
        case
        383597Pink201.000.0325
        (0.83)
        0.0435
        (1.10)
        1.656810.020/box 80/
        case
        383587Pink201.250.0325
        (0.83)
        0.0435
        (1.10)
        1.656410.020/box 80/
        case
        383599Pink201.750.0325
        (0.83)
        0.0435
        (1.10)
        1.65538.520/box 80/
        case
        383588Green181.250.0385
        (0.98)
        0.0515
        (1.31)
        1.659015.020/box 80/
        case
        393589Green181.750.0385
        (0.98)
        0.0515
        (1.31)
        1.658411.020/box 80/
        case

         

        *The catheter system has been tested at flow rates; however, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings these flow rates may not be achievable.

        Partner with BD

        Together we can elevate care. Our specialists are here to help.  Let's get started.

        BD Nexiva Diffusics™ Catheter System
        Ready to learn more? Let’s have a conversation.
        Resources
        Training

        Partner with BD

        Together we can elevate care. Our specialists are here to help.  Let's get started.

        BD Nexiva Diffusics™ Catheter System
        Ready to learn more? Let’s have a conversation.
        BD Nexiva™ Diffusics™ closed IV catheter system BD BD Nexiva Diffusics™ Closed IV Catheter System BD Nexiva Diffusics™ /content/dam/bd-assets/bd-com/en-us/logos/bd/header-bd-logo.svg

        Gain clarity where it counts

        fenestrated catheter